7 drug(s) with this reaction
2,594 total reports
Product Dose Omission Issue has been reported as an adverse reaction across 7 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,594 adverse event reports mention product dose omission issue in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with product dose omission issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have product dose omission issue listed in their FDA adverse event reports, sorted by report count:
In addition to product dose omission issue, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
7 drug(s) manufactured by Chattem Inc have product dose omission issue listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, MENTHOL, CAMPHOR, MENTHOL, and others.
There are a combined 2,594 reports of product dose omission issue across 7 Chattem Inc drug(s) in the FDA adverse event database.